A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity., Journal of Medical Genetics, vol.26, issue.11, pp.704-715, 1989. ,
DOI : 10.1136/jmg.26.11.704
Molecular genetics of neurofibromatosis type 1 (NF1)., Journal of Medical Genetics, vol.33, issue.1, pp.2-17, 1996. ,
DOI : 10.1136/jmg.33.1.2
Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Goteborg, Sweden, Acta Derm Venereol, vol.75, pp.136-176, 1995. ,
Long-term follow-up of von Reckilinghausen neurofibromatosis. Survival and malignant neoplams, N England J Med, vol.17, pp.1010-1015, 1986. ,
Clinical Risk Factors for Mortality in Patients With Neurofibromatosis 1, Archives of Dermatology, vol.139, issue.2, pp.187-91, 2003. ,
DOI : 10.1001/archderm.139.2.187
Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: A cohort study of 703 patients, American Journal of Medical Genetics Part A, vol.79, issue.1, pp.49-53, 2005. ,
DOI : 10.1002/ajmg.a.30394
A prospective study of neurofibromatosis type 1 cancer incidence in the UK, British Journal of Cancer, vol.70, issue.2, pp.233-241, 2006. ,
DOI : 10.1002/(SICI)1097-0142(19970601)79:11<2125::AID-CNCR9>3.0.CO;2-N
Mortality in Neurofibromatosis 1: An Analysis Using U.S. Death Certificates, The American Journal of Human Genetics, vol.68, issue.5, pp.1110-1118, 2001. ,
DOI : 10.1086/320121
URL : http://doi.org/10.1086/320121
Statistical methods in cancer research Volume II?The design and analysis of cohort studies, IARC Sci Publ, vol.82, pp.1-406, 1987. ,
Type 1 neurofibromatosis: A descriptive analysis of the disorder in 1,728 patients, American Journal of Medical Genetics, vol.131, issue.2, pp.138-181, 1997. ,
DOI : 10.1002/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U
Malignant peripheral nerve sheath tumours in neurofibromatosis 1, Journal of Medical Genetics, vol.39, issue.5, pp.311-315, 2002. ,
DOI : 10.1136/jmg.39.5.311
Association between benign and malignant peripheral nerve sheath tumors in NF1, Neurology, vol.65, issue.2, pp.205-216, 2005. ,
DOI : 10.1212/01.wnl.0000168830.79997.13
NF-1Score: A Prediction Score for Internal Neurofibromas in Neurofibromatosis-1, Journal of Investigative Dermatology, vol.130, issue.9, pp.2173-2181, 2010. ,
DOI : 10.1038/jid.2010.100
Schwann Cells From Human Neurofibromas Show Increased Proliferation Rates Under the Influence of Progesterone, Pediatric Research, vol.5, issue.1, pp.40-43, 2008. ,
DOI : 10.1203/PDR.0b013e31817445b8
An orthotopic xenograft model of intraneural NF1 MPNST suggests a potential association ,
http://www.ojrd.com/content/6/1/18 between steroid hormones and tumor cell proliferation, Orphanet Journal of Rare Diseases Lab Invest, vol.6, issue.87, pp.181092-102, 2007. ,
Analysis of steroid hormone effects on xenografted human NF1 tumor schwann cells, Cancer Biology & Therapy, vol.52, issue.8, pp.758-64, 2010. ,
DOI : 10.1158/1078-0432.CCR-09-1107
Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner, Neuro-Oncology, vol.13, issue.1, pp.28-41, 2011. ,
DOI : 10.1093/neuonc/noq146
Mortality Associated with Neurofibromatosis 1: A Cohort Study of 1895 Patients in 1980-2006 in France, Orphanet Journal of Rare Diseases, vol.6, issue.1, p.18, 2011. ,
DOI : 10.1093/neuonc/noq146
URL : https://hal.archives-ouvertes.fr/inserm-00593483